Founder & Managing Partner at Invivo Capital - Healthequity, Venture Capital investor in life sciences. PhD, neurosurgeon, Global Executive MBA (IESE). I paint.
THE INSIDE STORY OF AN INVESTMENT/ We are proud to announce that our portfolio company ESOBIOTEC is to be acquired by ASTRAZENECA in a landmark early-stage deal totaling $1B ($425M upfront), only 16 months after our investment. Read here: linkedin.com/posts/lluispar…
PORTFOLIO NEWS/ I’m proud to announce the first investment from our new fund, Invivo Ventures III. Neumirna Tx has secured a €20M Series A, led by Invivo Partners and Angelini Ventures (corporate arm of Angelini Pharma), to develop RNA-based therapies for drug-resistant epilepsy
PODCAST/ Here’s my conversation with Christian @Soschner where we talk about AI, Synbio, Art, and the Future of Mankind. Below is the original post from Christian with the full video (a little over 2 hours).